Mary O'Hearn

Enfuvirtide, an HIV-1 fusion inhibitor, for drug-resistant HIV infection in North and South America

New England Journal of Medicine · 2003 · 752 citations

Durable efficacy of enfuvirtide over 48 weeks in heavily treatment-experienced HIV-1-infected patients in the T-20 versus optimized background regimen only 1 and 2 clinical trials

Journal of acquired immune deficiency syndromes · 2005 · 128 citations